Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
"We strongly believe this novel TL1A directed antibody has the transformational potential to make a significant difference for patients living with inflammatory bowel disease and potentially other diseases," said Thomas Schinecker, CEO of Roche.
Source: https://www.hurriyetdailynews.com/roche-to-pay-7-1-bn-for-telavant-holdings-187271